⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | DSP Multi Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | DSP MF | HDFC MF |
| Category | Equity - Multi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹11.89 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | Nifty500 Multicap 50:25:25 - TRI | BSE Health Care - TRI |
| Fund Manager | Chirag Dagli | Nikhil Mathur |
| Inception | 30 Jan 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | -5.27% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 6.67% | 29.15% |
| Risk | ||
| 15.53 | 14.07 | |
| 1.01 | 0.59 | |
| 0.20 | 1.59 | |
| 2.24 | 21.67 | |
| 0.36 | 3.48 | |
| -11.03% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.68% | 1.03% |
| Exit Load | 1% on or before 12M, Nil after 12M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
DSP MF94%
HDFC MF94%
6.0%Only 6.0% of holdings by weight are common between DSP MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingDSP MFHDFC MF
Alkem Laboratories Ltd.3.26%4.64%
Cipla Ltd.2.72%4.15%
Category context: Equity vs Equity. Open the full Screener →